Literature DB >> 25552515

Association of Uric Acid With Vascular Stiffness in the Framingham Heart Study.

Tapan Mehta1, Eugene Nuccio2, Kim McFann2, Magdalena Madero3, Mark J Sarnak4, Diana Jalal2.   

Abstract

BACKGROUND: Uric acid is associated with increased risk of cardiovascular disease and arterial stiffness in patients with hypertension or stroke. It remains unknown if uric acid is associated with arterial stiffness in the general population.
METHODS: We analyzed the association between serum uric acid levels and measures of arterial stiffness such as carotid-femoral pulse wave velocity (CF PWV), carotid-radial pulse wave velocity (CR PWV) and augmentation index (AI) in 4,140 participants from the Generation 3 Framingham cohort using linear regression.
RESULTS: Mean (SD) age was 40.0 (8.8) years and mean (SD) serum uric acid levels were 5.3 (1.5) mg/dl. Mean (SD) CF PWV was 7.0 (1.4) m/s. Individuals in the highest quartile of uric acid were more likely to be male, have a higher prevalence of hypertension, higher BMI, fasting glucose and insulin, and lower estimated glomerular filtration rate (eGFR). Multivariate adjusted means of CF PWV were 6.90, 6.94, 7.06, and 7.15 m/s for uric acid quartile 1, 2, 3, and 4 respectively. In unadjusted analysis each 1mg/dl increase in uric acid was associated with higher CF-PWV (β = 0.27; 95% CI = 0.25, 0.29; P < 0.0001). This was attenuated but remained significant after adjusting for age, sex, smoking, hypertension, BMI, fasting glucose, insulin, animal protein intake, and eGFR (β= 0.06; 95% CI = 0.02, 0.09; P < 0.0007). There was no association between serum uric acid levels and AI upon adjustment for cardiovascular risk factors.
CONCLUSIONS: Serum uric acid levels are significantly associated with CF PWV and CR PWV in a younger Caucasian population. © American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; hypertension; uric acid; vascular stiffness.

Mesh:

Substances:

Year:  2014        PMID: 25552515      PMCID: PMC4542908          DOI: 10.1093/ajh/hpu253

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  41 in total

Review 1.  Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Authors:  Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-02       Impact factor: 8.311

2.  Prevalence and risk factors of overweight and obesity in China.

Authors:  Kristi Reynolds; Dongfeng Gu; Paul K Whelton; Xigui Wu; Xiufang Duan; Jingping Mo; Jiang He
Journal:  Obesity (Silver Spring)       Date:  2007-01       Impact factor: 5.002

3.  Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study.

Authors:  B F Culleton; M G Larson; W B Kannel; D Levy
Journal:  Ann Intern Med       Date:  1999-07-06       Impact factor: 25.391

4.  The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination.

Authors:  Greta Lee Splansky; Diane Corey; Qiong Yang; Larry D Atwood; L Adrienne Cupples; Emelia J Benjamin; Ralph B D'Agostino; Caroline S Fox; Martin G Larson; Joanne M Murabito; Christopher J O'Donnell; Ramachandran S Vasan; Philip A Wolf; Daniel Levy
Journal:  Am J Epidemiol       Date:  2007-03-19       Impact factor: 4.897

5.  Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.

Authors:  Stefan D Anker; Wolfram Doehner; Mathias Rauchhaus; Rakesh Sharma; Darrel Francis; Christoph Knosalla; Constantinos H Davos; Mariantonietta Cicoira; Waqar Shamim; Michel Kemp; Robert Segal; Karl Josef Osterziel; Francisco Leyva; Roland Hetzer; Piotr Ponikowski; Andrew J S Coats
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

6.  Relationship between serum uric Acid levels, metabolic syndrome, and arterial stiffness in korean.

Authors:  Ji Hyon Lim; Young-Kwon Kim; Yong-Seok Kim; Sang-Hoon Na; Moo-Yong Rhee; Myoung-Mook Lee
Journal:  Korean Circ J       Date:  2010-07-26       Impact factor: 3.243

7.  Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells.

Authors:  Sergey Zharikov; Karina Krotova; Hanbo Hu; Chris Baylis; Richard J Johnson; Edward R Block; Jawaharlal Patel
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-10       Impact factor: 4.249

8.  Relationships between serum uric acid, adiponectin and arterial stiffness in postmenopausal women.

Authors:  Jong Suk Park; Shinae Kang; Chul Woo Ahn; Bong Soo Cha; Kyung Rae Kim; Hyun Chul Lee
Journal:  Maturitas       Date:  2012-11-03       Impact factor: 4.342

9.  Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary Artery Risk Development in (Young) Adults.

Authors:  A R Dyer; K Liu; M Walsh; C Kiefe; D R Jacobs; D E Bild
Journal:  J Hum Hypertens       Date:  1999-01       Impact factor: 3.012

10.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.

Authors:  B N Ames; R Cathcart; E Schwiers; P Hochstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

View more
  33 in total

1.  Association between self-reported snoring and arterial stiffness: data from the Brisighella Heart Study.

Authors:  Arrigo F G Cicero; Martino Morbini; Riccardo Urso; Martina Rosticci; Angelo Parini; Elisa Grandi; Sergio D'Addato; Claudio Borghi
Journal:  Intern Emerg Med       Date:  2015-09-28       Impact factor: 3.397

2.  [Relationship between blood pressure variability and combined cardiovascular events in 5-10 years in hypertensive patients].

Authors:  Jun Liu; Rui-Xue DU; Liang Wang; Bin Zhu; Lei-Ming Luo
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-07-20

3.  Presence of tophi is a predictive factor of arterial stiffness in patients with gout.

Authors:  WooSeong Jeong; Seung-Jae Joo; Jinsoek Kim; Jae-Geun Lee; Joon Hyouk Choi
Journal:  Rheumatol Int       Date:  2019-06-01       Impact factor: 2.631

Review 4.  Hyperuricemia and Hypertension: Links and Risks.

Authors:  Douglas J Stewart; Valerie Langlois; Damien Noone
Journal:  Integr Blood Press Control       Date:  2019-12-24

Review 5.  The role of uric acid in mineral bone disorders in chronic kidney disease.

Authors:  Baris Afsar; Alan A Sag; Cinar Oztosun; Masanari Kuwabara; Mario Cozzolino; Adrian Covic; Mehmet Kanbay
Journal:  J Nephrol       Date:  2019-04-27       Impact factor: 3.902

Review 6.  Arterial Stiffness in Hypertension: an Update.

Authors:  Korshie Dumor; Michael Shoemaker-Moyle; Ravi Nistala; Adam Whaley-Connell
Journal:  Curr Hypertens Rep       Date:  2018-07-04       Impact factor: 5.369

7.  The Dietary Fructose:Vitamin C Intake Ratio Is Associated with Hyperuricemia in African-American Adults.

Authors:  Zihe Zheng; Jane L Harman; Josef Coresh; Anna Köttgen; Mara A McAdams-DeMarco; Adolfo Correa; Bessie A Young; Ronit Katz; Casey M Rebholz
Journal:  J Nutr       Date:  2018-03-01       Impact factor: 4.798

8.  Vascular Function and Uric Acid-Lowering in Stage 3 CKD.

Authors:  Diana I Jalal; Emily Decker; Loni Perrenoud; Kristen L Nowak; Nina Bispham; Tapan Mehta; Gerard Smits; Zhiying You; Douglas Seals; Michel Chonchol; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2016-09-12       Impact factor: 10.121

Review 9.  Hyperuricemia, Cardiovascular Disease, and Hypertension.

Authors:  Masanari Kuwabara
Journal:  Pulse (Basel)       Date:  2016-03-12

10.  Longitudinal Association Between Serum Uric Acid and Arterial Stiffness: Results From the Baltimore Longitudinal Study of Aging.

Authors:  Marco Canepa; Francesca Viazzi; James B Strait; Pietro Ameri; Roberto Pontremoli; Claudio Brunelli; Stephanie Studenski; Luigi Ferrucci; Edward G Lakatta; Majd AlGhatrif
Journal:  Hypertension       Date:  2016-12-12       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.